Clinical implications of serum digoxin concentrations

Area of Science:

• Pharmacology
• Clinical Medicine
• Cardiology

Background:

• Digoxin is a cardiac glycoside used to treat heart failure and arrhythmias.
• Understanding factors influencing serum digoxin concentrations and their correlation with toxicity is crucial for patient management.

Purpose of the Study:

• To assess factors influencing serum digoxin concentrations.
• To evaluate the relationship between serum digoxin levels and electrocardiographic (ECG) and clinical manifestations of toxicity.

Main Methods:

• Analysis of 463 hospitalized patients receiving beta-acetyldigoxin or beta-methyldigoxin.
• Assessment of age, sex, creatinine clearance, weight-corrected dose, and their impact on serum digoxin levels.
• Correlation of serum digoxin concentrations with ECG parameters (ST-segment depression, PR interval, QRS duration, QT interval, AV block) and clinical symptoms.

Main Results:

• Age, sex, creatinine clearance, and dose explained <7% of serum digoxin variability; creatinine clearance was the most significant factor.
• ST-segment depression increased with higher serum digoxin concentrations, but other ECG parameters and AV block were not associated with levels.
• Clinical toxicity symptoms (gastrointestinal, neuromuscular, psychiatric) did not correlate with serum digoxin concentrations.
• Ventricular rate in atrial fibrillation patients did not decrease with increasing digoxin levels.

Conclusions:

• Serum digoxin concentrations have limited value in assessing the degree of digitalization.
• Clinical and ECG findings are not consistently reliable indicators of digoxin levels or toxicity.
• Further research may be needed to establish better methods for monitoring digoxin therapy and toxicity.